Abbott Laboratories said Monday that it will pay $3.7 billion for Kos Pharmaceuticals Inc., in a move that will add two major cholesterol drugs to its product lineup.
*For more on this story,
read the full Marketwatch article.
Abbott Laboratories said Monday that it will pay $3.7 billion for Kos Pharmaceuticals Inc., in a move that will add two major cholesterol drugs to its product lineup.
*For more on this story,
read the full Marketwatch article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99